Literature DB >> 17161492

LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver.

Andrew M Miller1, Mina Masrorpour, Christian Klaus, Jian X Zhang.   

Abstract

BACKGROUND/AIMS: Thromboxane A2 (TXA2) has been suggested to play a significant role in the development of portal hypertension in fibrosis, and Kupffer cell (KC) derived TXA2 has been shown to mediate the hyperresponsiveness of the portal circulation to the vasoconstrictive actions of endothelin-1 (ET-1) during endotoxemia. The aim of this study was to determine whether the double stresses of prefibrotic changes and endotoxemia additively activate KC to increase release of TXA2 in response to ET-1, resulting in elevated portal resistance.
METHODS: One week Bile duct ligation (BDL) rats and sham-operated controls were subjected to isolated liver perfusions following LPS or saline for 6h. In a separate experiment, KC were isolated from BDL or sham rats and incubated with LPS or saline for 6h before the ET-1 treatment.
RESULTS: The double stresses of early fibrosis and LPS resulted in a greater sustained increase in portal pressure in response to ET-1 in BDL rats, and this increase correlated well with the much enhanced release of TXA2 in the perfusate. Media from the cultured KC showed significantly greater TXA2 release in response to ET-1 in BDL group than those in sham group, and LPS exacerbated this effect. Protein levels of cytosolic phospholipase A2 (cPLA2), cyclooxygenase-2, and thromboxane synthase were also significantly elevated in KC from BDL rats. ET-1 produced a marked increase in cPLA2 activation as measured by the phosphorylation of cPLA2 in KC of both BDL and sham groups. LPS greatly exacerbated the activation of cPLA2.
CONCLUSIONS: The data suggest that the double stresses additively activate KC with an upregulation of the key enzymes in the TXA2 biosynthesis and release increased amount of TXA2 via the augmented activation of cPLA2 in response to ET-1, which leads to the increased portal resistance and ultimately hepatic microcirculatory dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161492     DOI: 10.1016/j.jhep.2006.08.026

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Regulation of CRIg expression and phagocytosis in human macrophages by arachidonate, dexamethasone, and cytokines.

Authors:  Nick N Gorgani; Umaporn Thathaisong; Violet R S Mukaro; Ornnuthchar Poungpair; Amanda Tirimacco; Charles S T Hii; Antonio Ferrante
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

Review 2.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

3.  Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.

Authors:  Guiying Li; Weina Chen; Chang Han; Tong Wu
Journal:  J Hepatol       Date:  2011-04-14       Impact factor: 25.083

4.  Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients.

Authors:  Sheng-Lan Wang; Xin-Yan Zhu; Dong-Wei Zhang; Zhao-Jie Zhang; Heng-Jun Gao; Chang-Qing Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  TGF-beta and mesenchymal hepatic involvement after visceral leishmaniasis.

Authors:  Maria Irma Seixas Duarte; Heitor Franco de Andrade; Cleusa Fumica Hirata Takamura; Antonio Sesso; Felipe Francisco Tuon
Journal:  Parasitol Res       Date:  2008-12-05       Impact factor: 2.289

6.  Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Authors:  Kuei-Chuan Lee; Ying-Ying Yang; Ying-Wen Wang; Fa-Yauh Lee; Che-Chuan Loong; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

7.  Systemic and Splanchnic Lipopolysaccharide and Endothelin-1 Plasma Levels in Liver Cirrhosis before and after Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Jiaxiang Meng; Qing Wang; Kai Liu; Shuofei Yang; Xinxin Fan; Baochen Liu; Changsheng He; Xingjiang Wu
Journal:  Gastroenterol Res Pract       Date:  2016-01-31       Impact factor: 2.260

Review 8.  Prostanoids and Resolution of Inflammation - Beyond the Lipid-Mediator Class Switch.

Authors:  Tobias Schmid; Bernhard Brüne
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.